Related Experiment Videos
Failure to thrive in the elderly
1Arizona Center on Aging, Tucson, USA.
Clinics in Geriatric Medicine
|November 1, 1995
Summary
Failure to thrive in the elderly is a complex syndrome, not a diagnosis, involving weight loss and functional decline. It stems from nonorganic (psychosocial, physical) and organic (diseases, age-related changes) factors.
Area of Science:
- Gerontology
- Internal Medicine
- Clinical Syndromes
Background:
- Failure to thrive (FTT) is a prevalent geriatric syndrome characterized by progressive weight loss and functional deterioration.
- It is recognized as a syndrome, not a specific diagnosis, necessitating a comprehensive approach to understanding its etiology.
- FTT significantly impacts the quality of life and healthcare utilization in the elderly population.
Purpose of the Study:
- To delineate the multifactorial nature of failure to thrive in the elderly.
- To differentiate between nonorganic and organic causes for improved diagnostic and therapeutic strategies.
- To highlight the importance of a holistic assessment in managing this complex geriatric condition.
Main Methods:
- Review of existing literature on geriatric syndromes, specifically focusing on failure to thrive.
- Categorization of contributing factors into nonorganic (psychosocial, functional limitations) and organic (medical conditions, hormonal changes) domains.
- Synthesis of information to provide a framework for understanding and addressing FTT.
Main Results:
- Failure to thrive is consistently defined by progressive weight loss and decreased physical function.
- Nonorganic causes encompass psychosocial stressors and physical limitations impacting daily activities.
- Organic causes involve diagnosed diseases and potential age-related dysregulations in nutrition, inflammation, and hormonal balance.
Conclusions:
- Failure to thrive requires a syndromic approach, acknowledging its diverse origins.
- Distinguishing between nonorganic and organic factors is crucial for targeted interventions.
- Further research into age-associated physiological changes may uncover novel therapeutic targets for FTT.